Astragaloside IV alleviates macrophage senescence and d-galactose-induced bone loss in mice through STING/NF-κB pathway
International Immunopharmacology(2024)
摘要
•AS-IV impedes macrophage senescence and promotes osteogenic differentiation of BMSCs through the modulation of STING/NF-κB.•AS-IV treatment ameliorated macrophage senescence, abnormal bone microstructure, and bone mass loss in a mouse model of SOP.
更多查看译文
关键词
AS-IV,Macrophage senescence,SOP,STING,NF-κB pathway
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要